Middle East and Africa Neuropathic Pain Market, By Type (Spinal Cord Stimulation (SCS) Devices, External Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation (Tens) Devices), Product Type (Rechargeable and Non-Rechargeable), Procedure (Invasive and Non-Invasive), Technology (Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation and Respiratory Electrical Stimulation), Modality (Stationary and Portable), Mode of Purchase (Over-the-Counter Devices and Prescription-Based Devices), Pain Type (Peripheral Neuropathy, Entrapment Neuropathy, Phantom Limb Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Post Traumatic Neuropathy, Foot Pain, Coccydynia), Indication (Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Others), End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Third Party Distributor and Others) - Industry Trends and Forecast to 2030.
Middle East and Africa Neuropathic Pain Market Analysis and Size
Neuropathic pain is caused by a lesion or disease of the somatosensory system including peripheral fibres (Aβ, Aδ and C fibres) and central neurons and affects 7–10% of the general population. Multiple causes of neuropathic pain have been described and its incidence is likely to increase owing to the aging global population, increased incidence of diabetes mellitus and improved survival from cancer after chemotherapy.
Data Bridge Market Research analyses that the neuropathic pain market which was USD 0.41 billion in 2022, is expected to reach USD 2.02 billion by 2030, and is expected to undergo a CAGR of 9.2% during the forecast period of 2023 to 2030. “Spinal cord stimulation (SCS) devices” dominates the type segment of the Middle East and Africa neuropathic pain market owing to the rising prevalence of chronic diseases. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Neuropathic Pain Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Spinal Cord Stimulation (SCS) Devices, External Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation (Tens) Devices), Product Type (Rechargeable and Non-Rechargeable), Procedure (Invasive and Non-Invasive), Technology (Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation and Respiratory Electrical Stimulation), Modality (Stationary and Portable), Mode of Purchase (Over-the-Counter Devices and Prescription-Based Devices), Pain Type (Peripheral Neuropathy, Entrapment Neuropathy, Phantom Limb Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Post Traumatic Neuropathy, Foot Pain, Coccydynia), Indication (Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Others), End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Third Party Distributor and Others)
|
|
Countries Covered
|
South Africa, Saudi Arabia, U.A.E., Egypt, Israel And Rest Of Middle East And Africa
|
|
Market Players Covered
|
|
|
Market Opportunities
|
|
Market Definition
A form of persistent pain caused by injury to or functioning of the neurological system, particularly the peripheral nervous system, is known as neuropathy or simply "neuropathy" pain. Neuropathic pain, in contrast to conventional nociceptive pain, is brought on by aberrant signalling and processing of pain impulses inside the nervous system itself. Conventional nociceptive pain results from tissue damage (such as injury or inflammation).
Middle East and Africa Neuropathic Pain Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
The rising prevalence of chronic diseases such as diabetes, HIV/AIDS, and cancer in the region contributes to the incidence of neuropathic pain. As these conditions become more common, there is a greater demand for effective pain management solutions.
- Rising Availability of Alternative Therapies
There are chances to expand the range of available treatments for neuropathic pain due to the rising popularity of complementary and alternative therapies like acupuncture and herbal therapy.
- Increasing Geriatric Population
The population of the MEA region is ageing, which is causing a demographic shift. Older people are more likely to experience neuropathic pain, which increases the number of patients in need of care and pain management services.
Opportunities
- Increasing in Medical Tourism
Some MEA nations are marketing themselves as destinations for medical tourism, luring people looking for top-notch pain management therapies at reasonable costs.
- Rising in Healthcare Expenditure
Some nations in the MEA region are making investments in the construction of healthcare facilities such hospitals, clinics, and specialised pain management facilities. Patients with neuropathic pain may have easier access to pain management therapies as a result.
Restrains/Challenges
- Strict Regulations in Healthcare Sector
The regulatory framework for medical devices and pharmaceuticals can be complicated and differ from one nation to another. For businesses looking to advertise neuropathic pain therapies in the area, this may present difficulties.
- Economic Factors for Medication
Patients may find it challenging to pay for the expense of neuropathic pain drugs and therapies due to the region's economic inequalities. It is possible that many people lack insurance coverage for these procedures.
- Limited Access to Healthcare
In many parts of the Middle East and Africa, access to healthcare is limited, especially in rural areas. This can result in delayed diagnosis and treatment of neuropathic pain.
- Limited Funding for Research Programme
The discovery of novel and efficient treatments for neuropathic pain may be slowed down in some nations due to inadequate financing for medical research and development.
This Middle East and Africa neuropathic pain market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa neuropathic pain market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Middle East and Africa Neuropathic Pain Market Scope
The Middle East and Africa neuropathic pain market is segmented on the basis of the type, product type, procedure, technology, modality, mode of purchase, pain type, indication, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Type
- Spinal Cord Stimulation (SCS) Devices
- External Peripheral Nerve Stimulation
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
Product Type
- Rechargeable
- Non-Rechargeable
Procedure
- Invasive
- Non-Invasive
Technology
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Respiratory Electrical Stimulation
Modality
- Stationary
- Portable
Mode of Purchase
- Over-The-Counter Devices
- Prescription-Based Devices
Pain Type
- Peripheral Neuropathy
- Entrapment Neuropathy
- Phantom Limb Neuropathy
- Trigeminal Neuralgia
- Post herpetic Neuralgia (PHN)
- Post Traumatic Neuropathy
- Foot Pain
- Coccydynia
Indication
- Spinal Stenosis
- Chemotherapy-Induced Peripheral Neuropathy
- Diabetic Neuropathy
- Others
End Users
- Hospitals
- Clinics
- Home Healthcare
- Ambulatory Surgical Centers
- Others
Distribution Channel
- Direct Tender
- Third Party Distributor
- Others
Middle East and Africa Neuropathic Pain Market Regional Analysis/Insights
The Middle East and Africa neuropathic pain market is analysed and market size information is provided by the country, type, product type, procedure, technology, modality, mode of purchase, pain type, indication, end user and distribution channel as referenced above.
The countries covered in the Middle East and Africa neuropathic pain market report are, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa.
South Africa is dominating the Middle East and Africa neuropathic pain market owing to advancement in healthcare expenditure and funding.
Saudi Arabia is the fastest growing in the Middle East and Africa market owing to rising prevalence of chronic diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Middle East and Africa neuropathic pain market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Middle East and Africa neuropathic pain market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Middle East and Africa neuropathic pain market. The data is available for historic period 2015-2020.
Competitive Landscape and Middle East and Africa Neuropathic Pain market Share Analysis
Middle East and Africa Neuropathic pain market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Middle East and Africa neuropathic pain market.
Some of the major players operating in the Middle East and Africa neuropathic pain market are:
- AVNS (U.S.)
- B. Braun Melsungen AG (Germany)
- Medtronic (U.S.)
- Abbott (U.S.)
- Boston Scientific Corporation (U.S.)
- Omron Healthcare Inc. (Japan)
SKU-